- Report
- January 2023
- 127 Pages
North America
From €3038EUR$3,450USD£2,658GBP
- Report
- January 2023
- 166 Pages
Asia Pacific
From €3038EUR$3,450USD£2,658GBP
- Report
- January 2023
- 135 Pages
Middle East, Africa
From €3038EUR$3,450USD£2,658GBP
- Report
- October 2022
- 209 Pages
Global
From €3919EUR$4,450USD£3,428GBP
- Report
- September 2022
- 134 Pages
From €3038EUR$3,450USD£2,658GBP
- Report
- September 2022
- 157 Pages
Europe
From €3038EUR$3,450USD£2,658GBP
- Report
- September 2022
- 181 Pages
Asia Pacific
From €3038EUR$3,450USD£2,658GBP
- Report
- September 2022
- 150 Pages
Middle East, Africa
From €3038EUR$3,450USD£2,658GBP
- Report
- September 2022
- 127 Pages
North America
From €3038EUR$3,450USD£2,658GBP
- Report
- August 2022
- 104 Pages
From €3038EUR$3,450USD£2,658GBP
- Report
- August 2022
- 124 Pages
Asia Pacific
From €3038EUR$3,450USD£2,658GBP
- Report
- August 2022
- 112 Pages
Africa, Middle East
From €3038EUR$3,450USD£2,658GBP
- Report
- July 2022
- 120 Pages
North America
From €3038EUR$3,450USD£2,658GBP
- Report
- July 2022
- 132 Pages
Europe
From €3038EUR$3,450USD£2,658GBP
- Report
- July 2022
- 122 Pages
United Kingdom
From €3038EUR$3,450USD£2,658GBP
- Report
- March 2022
- 198 Pages
Global
From €3919EUR$4,450USD£3,428GBP
- Report
- February 2022
- 174 Pages
Global
From €3919EUR$4,450USD£3,428GBP
- Report
- November 2021
- 243 Pages
Global
From €3919EUR$4,450USD£3,428GBP
- Report
- November 2023
- 190 Pages
Global
From €3369EUR$3,825USD£2,946GBP
€3963EUR$4,500USD£3,466GBP
- Report
- July 2024
- 208 Pages
Global
From €5284EUR$6,000USD£4,622GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more